Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Alexion Pharma to pay $8.4 billion for rare disease treatment developer Synageva BioPharma
Alexion Pharma to pay $8.4 billion for rare disease treatment developer Synageva BioPharma
Alexion Pharma to pay $8.4 billion for rare disease treatment developer Synageva BioPharma
Submitted by
admin
on May 6, 2015 - 9:00am
Source:
Yahoo/AP
News Tags:
Alexion
M&A
SynaGeva BioPharma
Headline:
Alexion Pharma to pay $8.4 billion for rare disease treatment developer Synageva BioPharma
Do Not Allow Advertisers to Use My Personal information
